Miller Nash LLP: Cannabis & Taxes: Making Cents of Refunds and Reclassification
Justin Hobson Miller Nash LLP On April 30, 2024, the Associated Press announced the U.S. Drug Enforcement Agency (DEA) will move to reclassify cannabis from a Schedule I to Schedule III under the Controlled Substances Act. It is important to note that the move...
Clark Hill: Marijuana Rescheduling’s Impact on U.S. Customs and Border Patrol Interdiction of Drug Paraphernalia
May 2, 2024 R. Kevin Williams The Biden administration has proposed to reschedule marijuana from a Schedule I to Schedule III controlled substance. This reclassification will place marijuana in the same schedule as prescription drugs such as ketamine and Tylenol with...
Husch Blackwell: DEA Will Reschedule Cannabis to a Schedule III Drug
By Hilary Bricken, Steve Levine & Marshall Custer on April 30, 2024 The biggest legal shift in the cannabis industry in decades just occurred on the heels of the Drug Enforcement Administration’s (DEA) proposal today for cannabis rescheduling. Specifically, as...
Dorsey Whitney: It is a momentous day but lots more to come
“Cannabis is currently a Schedule 1 drug which includes drugs like heroin and LSD. The Biden administration is moving it to Schedule 3 which includes things like Tylenol with Codeine and steroids,” explains Stanton. “This is historic, because it is the first time...
Prince Lobel: Client Alert: DEA to Reclassify Cannabis
Today the Associated Press broke the news of the DEA’s long-awaited decision to move forward with the plan to reclassify cannabis from Schedule I to Schedule III. The change has been decades in the making, and comes as a consequence of President Biden’s October 2022...Top 200 Cannabis Lawyers
We Support